loading
Precedente Chiudi:
$1.76
Aprire:
$1.78
Volume 24 ore:
193.53K
Relative Volume:
1.24
Capitalizzazione di mercato:
$114.79M
Reddito:
-
Utile/perdita netta:
$-21.38M
Rapporto P/E:
-5.2821
EPS:
-0.39
Flusso di cassa netto:
$-25.19M
1 W Prestazione:
+12.57%
1M Prestazione:
+17.71%
6M Prestazione:
+129.14%
1 anno Prestazione:
+60.94%
Intervallo 1D:
Value
$1.78
$2.06
Intervallo di 1 settimana:
Value
$1.70
$2.06
Portata 52W:
Value
$0.51
$2.86

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Company Profile

Name
Nome
Connect Biopharma Holdings Ltd Adr
Name
Telefono
858-727-1040
Name
Indirizzo
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Name
Dipendente
62
Name
Cinguettio
Name
Prossima data di guadagno
2024-04-16
Name
Ultimi documenti SEC
Name
CNTB's Discussions on Twitter

Confronta CNTB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CNTB
Connect Biopharma Holdings Ltd Adr
2.06 98.07M 0 -21.38M -25.19M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.02 100.52B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
580.70 61.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
446.51 59.29B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
712.20 43.09B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
306.05 35.42B 3.81B -644.79M -669.77M -6.24

Connect Biopharma Holdings Ltd Adr Stock (CNTB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-12 Iniziato H.C. Wainwright Buy
2024-03-04 Iniziato H.C. Wainwright Buy
2021-04-13 Iniziato Jefferies Buy
2021-04-13 Iniziato Piper Sandler Overweight
2021-04-13 Iniziato SVB Leerink Outperform

Connect Biopharma Holdings Ltd Adr Borsa (CNTB) Ultime notizie

pulisher
Aug 29, 2025

Connect Biopharma (CNTB) Expected to Announce Quarterly Earnings on Friday - Defense World

Aug 29, 2025
pulisher
Aug 20, 2025

Connect Biopharma Advances Clinical Trials and Nasdaq Listing - AInvest

Aug 20, 2025
pulisher
Aug 18, 2025

Connect Biopharma Posts Q2 Revenue Drop - AOL.com

Aug 18, 2025
pulisher
Aug 18, 2025

Q3 Earnings Estimate for CNTB Issued By Leerink Partnrs - Defense World

Aug 18, 2025
pulisher
Aug 16, 2025

HC Wainwright Cuts Earnings Estimates for Connect Biopharma - Defense World

Aug 16, 2025
pulisher
Aug 14, 2025

Connect Biopharma Reports Q2 Revenue Drop of 99.2% to $48,000, R&D Spending Increases 65.6% to $8.8mln - AInvest

Aug 14, 2025
pulisher
Aug 13, 2025

Connect Biopharma Holdings Ltd SEC 10-Q Report - TradingView

Aug 13, 2025
pulisher
Aug 13, 2025

Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Aug 13, 2025
pulisher
Aug 06, 2025

Connect Biopharma Holdings Limited shares rise 5.63% after-hours following Jazz Pharmaceuticals' FDA approval of Modeyso. - AInvest

Aug 06, 2025
pulisher
Aug 01, 2025

Connect Biopharma Shares Rise on Plan to End ADR Program and Directly List on Nasdaq - MSN

Aug 01, 2025
pulisher
Jul 30, 2025

What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Jul 30, 2025
pulisher
Jul 27, 2025

Research Analysts Set Expectations for CNTB Q2 Earnings - MarketBeat

Jul 27, 2025
pulisher
Jul 25, 2025

Connect Biopharma (NASDAQ:CNTB) Upgraded at Northland Capmk - Defense World

Jul 25, 2025
pulisher
Jul 25, 2025

Q2 Earnings Estimate for CNTB Issued By Northland Capmk - Defense World

Jul 25, 2025
pulisher
Jul 22, 2025

Connect Biopharma stock rating reiterated as Outperform by Northland - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

Connect Biopharma appoints Jim Schoeneck to board of directors By Investing.com - Investing.com Nigeria

Jul 22, 2025
pulisher
Jul 22, 2025

Connect Biopharma appoints Jim Schoeneck to board of directors - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

Connect Biopharma appoints James A. Schoeneck to board of directors By Investing.com - Investing.com Nigeria

Jul 22, 2025
pulisher
Jul 22, 2025

Northland starts Connect Biopharma at Outperform on chance to define new class - TipRanks

Jul 22, 2025
pulisher
Jul 21, 2025

Connect Biopharma stock rises after announcing plan to terminate ADR program - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma to terminate ADR program, list ordinary shares By Investing.com - Investing.com India

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma to terminate ADR program, list ordinary shares - Investing.com

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma to Terminate ADR Program and List Ordinary Shares on Nasdaq - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma Announces Plans to Terminate its American - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

Connect Biopharma Streamlines Trading: ADRs Convert to Direct Nasdaq Shares in Major US Market Push - Stock Titan

Jul 21, 2025
pulisher
Jul 18, 2025

Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewswire Inc.

Jul 18, 2025
pulisher
Jul 17, 2025

Connect Biopharma regains Nasdaq compliance with minimum bid price rule - Investing.com India

Jul 17, 2025
pulisher
Jul 17, 2025

Connect Biopharma regains Nasdaq compliance with minimum bid price rule By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

Connect Biopharma regains Nasdaq compliance with $1 minimum bid price - Investing.com

Jul 17, 2025
pulisher
Jul 11, 2025

Connect Biopharma Holdings shares rise 7.89% in after-hours after partner's new drug application for atopic dermatitis is accepted by NMPA. - AInvest

Jul 11, 2025
pulisher
Jul 09, 2025

Connect Biopharma’s partner submits new drug application in China - Investing.com

Jul 09, 2025
pulisher
Jul 09, 2025

Connect Biopharma’s partner submits new drug application in China By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 08, 2025

Connect Biopharma (NASDAQ:CNTB) Trading Down 2.5% – Here’s What Happened - Defense World

Jul 08, 2025
pulisher
Jun 13, 2025

Connect Biopharma reports positive data for asthma treatment By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

Connect Biopharma reports positive data for asthma treatment - Investing.com

Jun 13, 2025
pulisher
May 13, 2025

Connect Biopharma begins Phase 2 asthma study - Investing.com

May 13, 2025
pulisher
Apr 04, 2025

Connect Biopharma stock hits 52-week low at $0.55 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Connect Biopharma stock hits 52-week low at $0.55 amid market challenges - Investing.com

Apr 04, 2025
pulisher
Apr 01, 2025

FDA greenlights Connect Biopharma’s asthma and COPD trials - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Connect Biopharma stock holds $8 target, Buy rating at H.C. Wainwright - Investing.com

Apr 01, 2025
pulisher
Mar 29, 2025

Connect Biopharma faces Nasdaq delisting over share price By Investing.com - Investing.com India

Mar 29, 2025
pulisher
Mar 28, 2025

Connect Biopharma faces Nasdaq delisting over share price - Investing.com

Mar 28, 2025
pulisher
Mar 27, 2025

Connect Biopharma stock hits 52-week low at $0.76 - Investing.com

Mar 27, 2025

Connect Biopharma Holdings Ltd Adr Azioni (CNTB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
Capitalizzazione:     |  Volume (24 ore):